- Slice of Manufacturing
- Posts
- Actylis Appoints Scott Thomson as New CEO
Actylis Appoints Scott Thomson as New CEO
Slice of Manufacturing Team
June 20, 2024
Key Highlights:
Scott Thomson appointed as CEO of Actylis.
Thomson brings three decades of industry experience.
Thomson previously served as CEO of SPI Pharma.
Actylis continues global growth and expansion under New Mountain Capital.
Source (Business Wire)
Notable Quotes
“Scott has an impressive tenure of driving long-term growth, and we look forward to welcoming Scott as we bring our client-centric, flexible customer service model and extensive product offerings to an increasing number of geographies, customers and applications.”
“We are excited for Scott to leverage and accelerate Actylis’ strong growth trajectory with increasing emphasis on high growth end markets and products.”
“Actylis has tremendous runway for sustainable growth due to its strong value proposition and market positioning. We are thrilled to invest further and support Scott and the management team to realize the company’s long-term strategic vision.”
“I feel privileged to lead the Actylis team at this exciting juncture, and I look forward to partnering with our customers, Actylis’ management and employees, and New Mountain to grow and further develop Actylis’ offerings.”
Our Take:
The appointment of Scott Thomson as CEO of Actylis marks a strategic move that leverages his extensive experience in the pharmaceutical and chemical industries. Thomson's proven track record at SPI Pharma and BASF highlights his capability to drive sustainable growth and strategic development. Under his leadership, Actylis is well-positioned to expand its global reach and enhance its product offerings, capitalizing on the robust support from New Mountain Capital. This leadership transition is poised to accelerate Actylis' growth trajectory, particularly in high-growth end markets and products, reinforcing its position as a leader in the life sciences and specialty chemicals markets.